However, limited evidence is available for the direct comparison of those using versus not using evidence-based cardiovascular preventive therapies (including: GLP-1 RA, SGLT2i, ACEI/ARB, statins, and aspirin) in terms of cardiovascular, hospitalization for heart failure and renal outcomes. Here, GLP1R is linked to heart failure.